ProjectSyndicate

(AKRO) akero therapeutics daily chart review by projectsyndicate

看多
NASDAQ:AKRO   Akero Therapeutics, Inc.
long-term buy and hold from 18
target is +70% near 30.
get ready to buy dips later in q1 2020.

MY LINKS OVERVIEW
🟡 TAPLINK.CC/PRSYNDICATE
75% WINS FREE/PREMIUM SIGNALS TELEGRAM
🔴 T.ME/THESYNDICATE001
LIFETIME BUNDLE FX/CRYPTO
🟡 SYNDICATE001.CC/
FREE GOLD TRADING SIGNALS
🟡 T.ME/SYNDICATEGOLD001
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。